Peiwei Yang
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 5
- CAR-T cell therapy research 5
-
- RNA modifications and cancer 2
- RNA Research and Splicing 2
- CRISPR and Genetic Engineering 1
- Co-authors
- Mengwei Li (4 shared papers)Hanmei Xu (5 shared papers)Heming Wu (4 shared papers)Shou‐Mei Wang (3 shared papers)Xiaojun Feng (3 shared papers)Hanmei Xu (2 shared papers)Yinan Zhang (3 shared papers)Erhao Zhang (2 shared papers)
In The Last Decade
Peiwei Yang
14 papers receiving 522 citations
Peers
Comparison fields: 5 of 64
- Cancer Research 135
- Oncology 174
- Immunology 102
- Molecular Biology 247
- Applied Microbiology and Biotechnology 5
Countries citing papers authored by Peiwei Yang
This map shows the geographic impact of Peiwei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peiwei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peiwei Yang more than expected).
Fields of papers citing papers by Peiwei Yang
This network shows the impact of papers produced by Peiwei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peiwei Yang. The network helps show where Peiwei Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Peiwei Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 85 | |
| 2 | 2021 | 74 | |
| 3 | 2020 | 61 | |
| 4 | 2019 | 59 | |
| 5 | 2018 | 45 | |
| 6 | 2020 | 43 | |
| 7 | 2021 | 39 | |
| 8 | 2021 | 29 | |
| 9 | 2022 | 25 | |
| 10 | 2020 | 23 | |
| 11 | 2022 | 20 | |
| 12 | 2023 | 13 | |
| 13 | 2024 | 8 | |
| 14 | 2017 | 1 |
About Peiwei Yang
Peiwei Yang is a scholar working on Oncology, Molecular Biology, Immunology, Pharmacology and Cancer Research, having authored 14 papers that have together received 525 indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), Immunotherapy and Immune Responses (2 papers), Flavonoids in Medical Research (2 papers), Immune Cell Function and Interaction (2 papers), RNA modifications and cancer (2 papers), Cancer-related molecular mechanisms research (2 papers), RNA Research and Splicing (2 papers) and CRISPR and Genetic Engineering (1 paper). The work is most often cited by research in Cancer Research (135 citations), Oncology (174 citations), Immunology (102 citations), Molecular Biology (247 citations) and Applied Microbiology and Biotechnology (5 citations). Peiwei Yang has collaborated with scholars based in China, Australia and France. Frequent co-authors include Mengwei Li, Hanmei Xu, Heming Wu, Shou‐Mei Wang, Xiaojun Feng, Hanmei Xu, Yinan Zhang, Erhao Zhang, Xiangying Chen and Shu‐Hui Zhang. Their work appears in journals such as Journal of the American Chemical Society, Cell Death and Disease, Signal Transduction and Targeted Therapy, Chemical Engineering Journal and Journal of Hematology & Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.